Anemia in hospitalized patients with cirrhosis: Prevalence, clinical relevance and predictive factors;Anemia en pacientes internados con cirrosis: Prevalencia, significación clínica y factores predictivos

Acta Gastroenterologica Latinoamericana

Volumn 39, Issue 2, 2009, Pages 103-111

  Mathurin, Sebastián Alfonso ^a,b   Agüero, Andrés Pablo ^a,c   Dascani, Natalia Andrea ^a   Prestera, Jorgelina Ana ^a   Gianserra, Carina ^a   Londero, Eliana ^a   Chiorra, Carolina ^a  

^a Hospital Intendente Carrasco   (Argentina)

^b UAI   (Italy)

^c NONE   (Argentina)

Author keywords

Cirrhosis; anemia; Hospital mortality; Renal failure

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; HEMOGLOBIN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ALCOHOLISM; ANEMIA; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTION; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PREVALENCE; PROGNOSIS; RISK; RISK FACTOR; SCORING SYSTEM;

EID: 68249155094     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. D'Amico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spano C, Pagliaro L. Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology 1990;99:1558-1564.
2. Malik P, Bogetti D, Sileri P, Testa G, Blumenthal SA, Wiley TE, Layden TJ, Benedetti E. Spur cell anemia in alcoholic cirrhosis: cure by orthotopic liver transplantation and recurrence after liver graft failure. Int Surg 2002;87:201-204.
3. Liangpunsakul S, Ulmer BJ, Chalasani N. Predictors and implications of severe hypersplenism in patients with cirrhosis. Am J Med Sci 2003;326:111-116. (Pubitemid 37122293)
4. Ohki I, Dan K, Kuriya S, Nomura T. A study on the mechanism of anemia and leucopenia in liver cirrhosis. Jpn J Med 1988;27:155-159. (Pubitemid 18180052)
5. Patt CH, Fairbanks KD, Thuluvath PJ. Renal insufficiency may partly explain chronic anemia in patients awaiting liver transplantation. Dig Dis Sci 2004;49:629-632.
6. Chao TC, Chen CY, Yang YH, Chen PM, Chang FY, Lee SD. Chronic hepatitis C virus infection associated with primary warm-type autoimmune hemolytic anemia. J Clin Gastroenterol 2001;33:232-233. (Pubitemid 32762896)
7. García de Casasola G, Cárdenas Franco C, Vegas Serrano A, Hornero Izquierdo MA, Guijarro Herraiz C, Zapatero Gaviria A. La anemia es un factor pronóstico de mortalidad en la insuficiencia cardíaca. An Med Interna 2005;22:271-274. (Pubitemid 41133971)
8. Forrest EH, Evans CDJ, Stewart S, Philips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP, Hayes PC, Murray LS, Morris AJ. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of de Glasgow alcoholic hepatitis score. Gut 2005;54:1174-1179. (Pubitemid 41025916)
9. Kulkarni K, Tran T, Medrano M, Yoffe B, Goodgame R. The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 2004;38:453-459.
10. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerichs J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164-176.
11. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. Circulation 2003;107:223-225.
12. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786. (Pubitemid 34595288)
13. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorgiade M, O'Connor CM. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 2003;92:625-628.
14. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928-1936. (Pubitemid 34700619)
15. Caramelo C, Gil P. Insuficiencia combinada cardiorrenal: una entidad emergente. Med Clin (Barc) 2003;121:710-717. (Pubitemid 38155372)
16. Kalra PR, Bolger AP, Francis DP, Genth-Zotz S, Sharma R, Ponikowski PP, Poole-Wilson PA, Coats AJ, Anker SD. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 2003;91:888-891. (Pubitemid 36363742)
17. Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G; Schwartz D, Baruch R, Yachnin T, Shaked M, Schwartz I, Steinbruch S, Iaina A. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003;18:141-146. (Pubitemid 36104490)
18. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. A consensus workshop of the international ascites club. Gut 2007;56:1310-1318. (Pubitemid 47300435)
19. Ruiz del Arbol L, Urman J, Fernández J, Gonzalez M, Navasa M, Monescillo A, Albillos A, Jimenez W, Arroyo V. Systemic, renal and hepatic haemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38:1210-1218. (Pubitemid 37314829)
20. Wadei HM, Mai ML, Ahsan N, Gonwa TA. Hepatorenal syndrome: pathophysiology and management. Clin J Med Soc Nephrol 2006;1:1066-1079.
21. Ginés A, Escorsell A, Ginès P, Salo J, Jiménez W, Inglada L, Navasa M Claria J, Rimola A, Arroyo V, Rodrés J. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-236. (Pubitemid 23234041)
22. Jones M, Ibels L, Schenkel B, Zagari M. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: analysis. Kidney Int 2004;65:757-767. (Pubitemid 38251052)
23. Cirera I, Elizalde JI, Piqué JM, Feu F, Casedevall M, Goldin E, Teres J, Bosch J, Rodes J. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci 1997;42:1697-1702. (Pubitemid 27394593)
24. Siciliano M, Tomasello D, Milani A, Ricerca BM, Storti S, Rossi L. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia. Hepatology 1995;22:1132-1135.
25. Pirisi M, Fabris C, Falleti E, Soardo G, Toniutto P, Gonano F, Bartoli E. Evidence for a multifactorial control of serum erythropoietin concentration in liver disease. Clin Chim Acta 1993;219;47-55. (Pubitemid 23332660)
26. Moreau R, Durand F, Poynard T, Moreau R, Durand F, Poynard T, Duhamel C, Cervoni JP, Ichaï P, Abergel A, Halimi C, Pauwels M, Bronowicki JP, Giostra E, Fleurot C, Gurnot D, Nouel O, Renard P, Rivoal M, Blanc P, Coumaros D, Ducloux S, Levy S, Pariente A, Perarnau JM, Roche J, Scribe-Outtas M, Valla D, Bernard B, Samuel D, Butel J, Hadengue A, Platek A, Lebrec D, Cadranel JF. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002; 122:923-930. (Pubitemid 34267275)
27. Mathurin S, Jaimet C, Turletti C, Arosio A, Gonzalez G, Kuzmicz G. Insuficiencia renal en pacientes con cirrosis y ascitis: incidencia, etiología y factores predictivos. Acta Gastroenterol Latinoam 2008;38:116-125.
28. Wu CC, Yeung LK, Tsai WS, Tseng CF, Chu P, Huang TY, Lin YF, Lu KC. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol 2006;65:28-33. (Pubitemid 43091692)